CBIO vs UHS · rev $1.0M vs P/E 5.9, rev $9.13B
Crescent Biopharma, Inc. (CBIO) versus Universal Health Services Inc (UHS) — a side-by-side from cached financials, not a winner call.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
Universal Health Services Inc (UHS) is a medical care facilities company listed on NYSE.
Latest reported CBIO revenue for 2026-06-30 was $1.0M. Net income was -$48.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. CBIO currently screens at market cap $491.3M.
Latest reported UHS revenue for 2026-06-30 was $9.13B. Net income was $707.1M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
CBIO currently screens at market cap $491.3M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
Not investment advice. Open the CBIO and UHS stock pages for the full models.
Not investment advice.